Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002

de Pedro-Cuesta, Jesús; Glatzel, Markus; Almazán, Javier; Stoeck, Katharina; Mellina, Vittorio; Puopolo, Maria; Pocchiari, Maurizio; Zerr, Inga; Kretszchmar, Hans A.; Brandel, Jean-Philippe; Delasnerie-Lauprêtre, Nicole; Alpérovitch, Annick; van Duijn, Cornelia; Sanchez-Juan, Pascual; Collins, Steven; Lewis, Victoria; Jansen, Gerard H.; Coulthart, Michael B.; Gelpi, Ellen; Budka, Herbert
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p278
Academic Journal
Background: The objective of this study was to describe the diagnostic panorama of human transmissible spongiform encephalopathies across 11 countries. Methods: From data collected for surveillance purposes, we describe annual proportions of deaths due to different human transmissible spongiform encephalopathies in eleven EUROCJD-consortium countries over the period 1993-2002, as well as variations in the use of diagnostic tests. Using logistic models we quantified international differences and changes across time. Results: In general, pre-mortem use of diagnostic investigations increased with time. International differences in pathological confirmation of sporadic Creutzfeldt-Jakob disease, stable over time, were evident. Compared to their counterparts, some countries displayed remarkable patterns, such as: 1) the high proportion, increasing with time, of variant Creutzfeldt-Jakob disease in the United Kingdom, (OR 607.99 95%CI 84.72-4363.40), and France (OR 18.35, 95%CI 2.20-152.83); 2) high, decreasing proportions of iatrogenic Creutzfeldt-Jakob disease in France, (OR 5.81 95%CI 4.09-8.24), and the United Kingdom, (OR 1.54 95%CI 1.03-2.30); and, 3) high and stable ratios of genetic forms in Slovakia (OR 21.82 95%CI 12.42-38.33) and Italy (OR 2.12 95%CI 1.69-2.68). Conclusion: Considerable international variation in aetiological subtypes of human transmissible spongiform encephalopathies was evident over the observation period. With the exception of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease in France and the United Kingdom, these differences persisted across time.


Related Articles

  • French target research money at allaying BSE fears. Butler, Declan // Nature;11/23/2000, Vol. 408 Issue 6811, p392 

    Focuses on plans of the French government to increase funding for research on prions which are suspected of causing bovine spongiform encephalopathy (BSE) in cattle. Intention to develop therapeutic methods for controlling variant Creutzfeldt-Jakob disease, the human form of BSE; Concern in...

  • CJD cash plea.  // New Scientist;11/16/96, Vol. 152 Issue 2056, p11 

    Reports that the British Medical Research Council is pressing for a meeting with drug industry chiefs to secure funding to investigate possible treatments for Creutzfeldt-Jakob disease.

  • Virus may be cause of CJD.  // OR Manager;Mar2007, Vol. 23 Issue 3, p32 

    The article discusses research being done on the Creutzfeldt-Jakob disease (CJD). It references a study by Manuelidis et al published in the January 31, 2007 online issue of the "Proceedings of the National Academy of Science." The researchers claim that they found a virus-like particles in...

  • Growth hormone deaths blamed on MRC and DoH. Dyer, Clare // BMJ: British Medical Journal (International Edition);7/27/96, Vol. 313 Issue 7051, p185 

    Reports that a High Court judge held the Department of Health and the Medical Research Council responsible for the deaths of young adults from Creutzfeldt-Jakob disease (CJD) who had been treated with human growth hormone. Compensation claims of family survivors; Background on the growth...

  • Buying time.  // New Scientist;04/21/2001, Vol. 170 Issue 2287, p13 

    Reports on research effort at the University of California which attempts to slow onset and spread of prion diseases such as Creutzfeldt-Jakob disease (CJD) through use of alien prions. Effect of PrP proteins from a hamster on a mouse infected with abnormal PrP; Problems with delivery;...

  • MRC to open new CJD research unit... Dove, Alan // Nature Medicine;Dec1998, Vol. 4 Issue 12, p1347 

    Announces the British Medical Research's Council (MRC) opening of a research center to study Creutzfeldt Jacob Disease (CJD). Task of developing tests for CJD in human tissue samples; Plan of carrying out anonymous screening of tonsil tissue removed during surgery from patients later found.

  • Prion Removal Filter Technology. Bates, Megyn // Pharmaceutical Technology;Nov2004, Vol. 28 Issue 11, p24 

    The article informs that because of the recent occurrences of variant Creutzfeldt-Jakob disease, in Great Britain, Pall Corporation (East Hills, New York, www.pall.com) is investigating the transmission and control of the bloodborne prions (infectious protein agents) thought to be responsible....

  • Prior infection saved British from vCJD.  // New Scientist;10/29/2005, Vol. 188 Issue 2523, p19 

    The article focuses on reasons behind the low death toll from variant Creutzfeldt-Jakob (vCJD) disease in Great Britain. It is expected that the death tool from the disease decreased because most people were protected through prior infection with an as yet unidentified milder strain of agent...

  • RESEARCH BRIEFS.  // GP: General Practitioner;4/28/2006, p2 

    The article presents news briefs related to medicine from around the world. Probiotics might help to reduce gut symptoms caused by long-term stress, say Canadian researchers. They mimicked psychological stress conditions and found that there was boosted adherence of harmful bacteria to the gut...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics